Winnie Liu1, David R Saxon2, Bryan McNair3, Rebecca Sanagorski4, Neda Rasouli5. 1. University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA Colorado School of Public Health, Department of Biostatistics and Informatics, Aurora, CO, USA. 2. Division of Endocrinology, Metabolism, and Diabetes, University of Colorado School of Medicine, Aurora, CO, USA Denver Veterans Affairs Medical Center, Denver, CO, USA Colorado School of Public Health, Department of Biostatistics and Informatics, Aurora, CO, USA. 3. Colorado School of Public Health, Department of Biostatistics and Informatics, Aurora, CO, USA. 4. Denver Veterans Affairs Medical Center, Denver, CO, USA. 5. Division of Endocrinology, Metabolism, and Diabetes, University of Colorado School of Medicine, Aurora, CO, USA Denver Veterans Affairs Medical Center, Denver, CO, USA NEDA.RASOULI@ucdenver.edu.
Abstract
BACKGROUND: Rates of diabetes for veterans who receive health care through the Veterans Health Administration are higher than rates in the general population. Furthermore, many veterans live in rural locations, far from Veterans Affairs (VA) hospitals, thus limiting their ability to readily seek face-to-face endocrinology care for diabetes. Telehealth (TH) technologies present an opportunity to improve access to specialty diabetes care for such patients; however, there is a lack of evidence regarding the ability of TH to improve glycemic control in comparison to traditional face-to-face consultations. METHODS: This was a retrospective cohort study of all new endocrinology diabetes consultations at the Denver VA Medical Center over a 1-year period. RESULTS: A total of 189 patients were included in the analysis. In all, 85 patients had received face-to-face (FTF) endocrinology consultation for diabetes and 104 patients had received TH consultation. Subjects were mostly males (94.7%) and the mean age was 62.8 ± 10.1 years old. HbA1c improved from 9.76% (9.40% to 10.11%) to 8.55% (8.20% to 8.91%) (P < .0001) for the TH group and from 9.56% (9.16% to 9.95%) to 8.62% (8.22% to 9.01%) (P < .0001) for the FTF group after 1 visit. This change in HbA1c was not significantly different in the TH and FTF groups (P = .24). TH visits were associated with a hypothetical savings in median distance traveled of 231.2 miles per trip (which equates to $94.79 saved per trip). CONCLUSIONS: Endocrinology TH consultations improved short-term glycemic control as effectively as traditional FTF visits in a veteran population with diabetes.
BACKGROUND: Rates of diabetes for veterans who receive health care through the Veterans Health Administration are higher than rates in the general population. Furthermore, many veterans live in rural locations, far from Veterans Affairs (VA) hospitals, thus limiting their ability to readily seek face-to-face endocrinology care for diabetes. Telehealth (TH) technologies present an opportunity to improve access to specialty diabetes care for such patients; however, there is a lack of evidence regarding the ability of TH to improve glycemic control in comparison to traditional face-to-face consultations. METHODS: This was a retrospective cohort study of all new endocrinology diabetes consultations at the Denver VA Medical Center over a 1-year period. RESULTS: A total of 189 patients were included in the analysis. In all, 85 patients had received face-to-face (FTF) endocrinology consultation for diabetes and 104 patients had received TH consultation. Subjects were mostly males (94.7%) and the mean age was 62.8 ± 10.1 years old. HbA1c improved from 9.76% (9.40% to 10.11%) to 8.55% (8.20% to 8.91%) (P < .0001) for the TH group and from 9.56% (9.16% to 9.95%) to 8.62% (8.22% to 9.01%) (P < .0001) for the FTF group after 1 visit. This change in HbA1c was not significantly different in the TH and FTF groups (P = .24). TH visits were associated with a hypothetical savings in median distance traveled of 231.2 miles per trip (which equates to $94.79 saved per trip). CONCLUSIONS: Endocrinology TH consultations improved short-term glycemic control as effectively as traditional FTF visits in a veteran population with diabetes.
Authors: Herbert J Rogove; Benjamin Amoateng; Jennifer Binner; Bart M Demaerschalk; Richard B Sanders Journal: Telemed J E Health Date: 2015-02-11 Impact factor: 3.536
Authors: June McKoy; Karen Fitzner; Miranda Margetts; Elizabeth Heckinger; James Specker; Laura Roth; Maxwell Izenberg; Molly Siegel; Shannon McKinney; Gail Moss Journal: Popul Health Manag Date: 2014-10-07 Impact factor: 2.459
Authors: Amneet Sandhu; P Michael Ho; Steve Asche; David J Magid; Karen L Margolis; JoAnn Sperl-Hillen; Bill Rush; David W Price; Heidi Ekstrom; Heather Tavel; Olga Godlevsky; Patrick J O'Connor Journal: Am Heart J Date: 2015-03-31 Impact factor: 4.749
Authors: Stephanie Chu; Richard Boxer; Pauline Madison; Leonard Kleinman; Ted Skolarus; Lisa Altman; Carol Bennett; Jeremy Shelton Journal: Urology Date: 2015-07-11 Impact factor: 2.649
Authors: Ravi K Gopal; Pooja Solanki; Barbara G Bokhour; Natalia Skorohod; Deisy Anahí Hernandez Lujan; WonJun Choi; Howard S Gordon Journal: J Nurse Pract Date: 2021-05 Impact factor: 0.767
Authors: Matthew F Bouchonville; Margaret M Paul; John Billings; Jessica B Kirk; Sanjeev Arora Journal: Curr Diab Rep Date: 2016-10 Impact factor: 4.810